Image: BBC Technology
Palantir faces intense scrutiny over its NHS data contracts, as UK MPs raise security concerns. Discover the implications for healthcare data management.
GlipzoPalantir Technologies is currently under fire in the UK as demands for greater oversight of its data usage in NHS contracts intensify. The company, which specializes in big data analytics, has recently come into the spotlight due to a directive from NHS England urging all trusts to adopt Palantir's "core products" in hospitals starting this month. This move has sparked significant concern among various political leaders and advocacy groups, who question the implications of involving a foreign tech company with sensitive patient information.
Emily Darlington, a Labour MP, voiced her apprehensions during a BBC interview, labeling the involvement of a "foreign tech company" with patient data as a "major security risk." The backlash does not stop there; the Liberal Democrats have echoed similar sentiments, asserting that Palantir should be excluded from the UK's national security infrastructure. Zack Polanski, leader of the Green Party, has also criticized the firm, describing it as a "military surveillance company."
Moreover, Wendy Morton, a Conservative MP, has joined the chorus of voices demanding rigorous scrutiny of Palantir's ability to safeguard data. The growing opposition highlights the contentious nature of Palantir's role in health data management, especially given its controversial background.
In late 2023, Palantir secured a £300 million contract with NHS England to provide its Foundry Federated Data Platform (FDP). This platform is designed to resolve issues stemming from the NHS's disparate IT systems, which have long hindered efficient patient care. By integrating incompatible databases, the FDP aims to streamline access to vital information regarding waiting lists, hospital supplies, and bed availability.
During a recent appearance on the BBC's Politics Live, Louis Mosley, Palantir's UK executive vice-chair, defended the company's operations, expressing confidence that it is effectively serving the needs of patients. He emphasized the fragmented nature of the NHS, stating, "Those of us who use the NHS experience disconnected systems that require us to repeatedly explain our circumstances to various personnel. Joining up that information is what we are doing for the NHS."
Mosley further argued that Palantir’s software represents good value for money and dismissed concerns about data security. He stated, "We have no interest in patient data in the UK... It’s not our business model." He likened their role to that of Microsoft software used within the NHS, asserting that neither Palantir nor Microsoft has access to NHS data.
Despite the backlash, some politicians have come forward to support Palantir's involvement in NHS contracts. Labour MP Alex McIntyre, who is part of the Commons Health and Social Care select committee, emphasized that strict guidelines are in place to ensure data remains within the UK and is NHS-owned. He reassured the public that Palantir does not have the capability to share patient data for its own needs.
However, critics are not easily swayed. The company’s connections to the CIA, allegations of surveillance, and its contracts with the Israeli Defence Force raise red flags for many. Concerns have also been raised regarding Palantir’s owner, Peter Thiel, who has made significant donations to former President Donald Trump’s campaign.
Emily Darlington further articulated her concerns regarding the NHS contract on the BBC's World at One program, emphasizing the potential security risks involved with entrusting sensitive patient data to a company whose CEO has made disparaging remarks about the NHS. She stated, “The NHS is the biggest health service in the world with the biggest amount of patient data... It's a major security risk if you're working with a company whose chief executive talks about the NHS as a 'delusion.'"
These values-driven concerns resonate with many who fear the implications of foreign influence on the UK’s healthcare system. Sir Ed Davey, the leader of the Liberal Democrats, has called on Health Secretary Wes Streeting to terminate the contract with Palantir, urging that American tech firms with controversial backgrounds should not handle British citizens' health data.
As the controversy unfolds, Palantir's contract with NHS England is set to be reviewed at the beginning of next year. The outcome of this scrutiny will likely depend on ongoing political pressure and public sentiment regarding data privacy and security. The situation raises critical questions about the future role of foreign tech companies in the UK healthcare system and the balance between technological advancement and safeguarding sensitive information.
In summary, the debate surrounding Palantir’s role in the NHS reflects broader concerns about data security, sovereignty, and the ethics of foreign involvement in national health services. The coming months will be critical in shaping the future landscape of healthcare data management in the UK.
Confused about chest pain? Discover how to differentiate between gas discomfort and heart-related issues to ensure timely medical action.
Indian Express
Austrian police warn of rat poison found in HiPP baby food jars. Stay vigilant and learn how to identify tampered products. Read more for details.
BBC World
Health visitors in England face crushing caseloads of over 1,000 families, prompting urgent calls for limits to ensure proper care for children and families.
BBC Health